Elanco Animal Health Incorporated (ELAN) vs Viatris Inc. (VTRS)

Elanco Animal Health Incorporated and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $21.8B against $11.8B — 1.8× the size. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 4.27%. Elanco Animal Health Incorporated has the higher net margin (−3.96% vs −4.13%) and the higher return on invested capital (0.51% vs −0.02%). Across the 20 metrics below, Elanco Animal Health Incorporated leads on 11 and Viatris Inc. on 9.

Valuation

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 2.36 1.49 2.08
P/B 1.80 1.61 1.79
Price to free cash flow 33.22 10.69 16.29
EV/EBITDA 19.70 12.34 12.22
EV/Sales 3.04 2.28 2.87
Earnings yield (1.73%) (2.81%) (15.94%)
Free cash flow yield 3.01% 9.35% 0.00%

Profitability

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Gross margin 55.36% 35.31% 53.51%
Operating margin 1.61% (0.03%) 0.00%
Net margin (3.96%) (4.13%) (2.45%)
Free cash flow margin 7.55% 16.27% 0.00%
Return on equity (2.98%) (4.21%) (0.80%)
Return on assets (1.46%) (1.67%) (1.67%)
Return on invested capital 0.51% (0.02%) 0.00%

Growth

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 11.95% 4.27% 5.22%
EPS growth (last fiscal year) (169.12%) (466.04%) 42.91%
Revenue growth, 5-year CAGR 7.59% 3.66% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.59 0.13 0.04
Current ratio 2.05 1.55 2.41
Net debt to EBITDA 5.00 4.92 1.01

Dividend

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Dividend yield — 2.54% 1.45%
Payout ratio — — 0.27

Size

Metric ELAN VTRS Drug Manufacturers Specialty & Generic median
Market cap 11.83b 21.79b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack